Half of primary care physicians surveyed ranked Pfizer's Web site as the top corporate pharmaceutical site, according to a survey by Manhattan Research. The survey found that Merck had 44% of market share, Eli Lilly had 25% of market share, GlaxoSmithKline had 24% of market share and Novartis had 22% of market share.
Full Article from iHealthBeat